| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |